88546-55-8

• 常用中文名：奥美拉唑砜
• 常用英文名：Omeprazole Sulfone
• CAS号：88546-55-8
• 分子式：C₁₇H₁₉N₃O₄S
• 分子量：361.415
• 相关类别： 分析化学 分析试剂 离子色谱试剂
• 发布时间：2018-07-14 14:38:25
• 更新时间：2026-07-01 15:52:41
• Omeprazole sulfone是Omeprazole的代谢物。

名称

• 中文名: 奥美拉唑杂质A
• 英文名: 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfonyl]-1H-benzimidazole
• 中文别名: 奥美拉唑杂质D 标准品; 奥美拉唑杂质Ⅰ(5-甲氧基-2-[[(4-甲氧基-3,5_二甲基-2-吡啶基)甲基]磺酰基]-1 H -苯并咪唑); 艾司奥美拉唑钠杂质Ⅰ5-甲氧基-2-[[(4-甲氧基-3,5-二甲基-2吡啶基)甲基]磺酰基]-1H-苯并咪唑; 埃索美拉唑钠杂质D; 奥美拉唑杂质D(奥美拉唑砜); 埃索美拉唑杂质; 埃索美拉唑杂质4; 埃索美拉唑镁杂质D; 奥美拉唑镁杂质D; 奥美拉唑杂质Ⅰ(5-甲氧基-2-[[(4-甲氧基-3，5_二甲基-2-吡啶基）甲基]磺酰基]-1 H -苯并咪唑); 奥美拉唑钠杂质Ⅰ(5-甲氧基-2-[[(4-甲氧基-3,5-二甲基-2-吡啶基)甲基]磺酰基]-1H-苯并咪唑); 奥美拉唑杂质 D; 埃索美拉唑三水镁盐D); 埃索美拉唑杂质4 (奥美拉唑杂质D); 奥美拉唑杂质D/C1A; 艾司奥美拉唑杂质D(H168/66); 奥美拉唑杂质A 奥美拉唑砜; 奥美拉唑(艾司奥美拉唑镁)杂质D(奥美拉唑砜杂质D对照品); 奥美拉唑 D; 奥美拉唑钠杂质Ⅰ; 奥美拉唑杂质D:奥美拉唑杂质D; 艾司奥美拉唑镁肠溶片杂质Ⅰ; 埃索美拉唑EP杂质D; 奥美拉唑相关物质A 标准品; 5-甲氧基-2-[[(4-甲氧基-3,5-二甲基-2-吡啶基)甲基]磺酰基]-1H-苯并咪唑; 艾司奥美拉唑镁肠溶片杂质Ⅰ5-甲氧基-2-[[(4-甲氧基-3,5-二甲基-2-吡啶基)甲基]磺酰基]-1H-苯并咪唑; 奥美拉唑镁肠溶片杂质Ⅰ; 奥美拉唑D杂质; 埃索美拉唑中间体/奥美拉唑砜; 奥美拉唑镁肠溶片杂质Ⅰ(5-甲氧基-2-[[(4-甲氧基-3,5-二甲基-2-吡啶基)甲基]磺酰基]-1H-苯并咪唑); 2-[[(3,5-二甲基-4-甲氧基-2-吡啶基)甲基]磺酰基]-5-甲氧基苯并咪唑; 奥美拉唑杂质D /BP); 罗恩 奥美拉唑砜 R112439; 奥美拉唑杂质Ⅰ; 奥美拉唑砜/奥美拉唑磺酰化物; 进口标准杂质H168/66; 奥美拉唑相关化合物A/奥美拉唑磺酰化物; 奥美拉唑相关物质A; 埃索美拉唑杂质D(H168/66); 奥美拉唑相关化合物A; 埃索美拉唑镁杂质D/奥美拉唑杂质D 标准品; 奥美拉唑钠杂质D; 埃索美拉唑杂质D; 5-甲氧基-2-(((4-甲氧基-3,5-二甲基吡啶-2-基)甲基)磺酰基)-1H-苯并[D]咪唑; 艾司奥美拉唑杂质H168/66; 埃索美拉唑杂质D/奥美拉唑杂质D
• 英文别名: OMrazole Related CoMpound A; omrazole Imp-D (sulfoxide); EsoMrazole related substance D; Omeprazole sulfone; 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole; Amlodipine Impurity F; Omrazole Impurity D：Omrazole Impurity D; H168/66; Esomrazole Impuritie D; OMRAZOLE IMP. A :5-METHOXY-1H-BENZIMIDAZOLE-2-THIOL MM STANDD; OMrazole IMpurity D; Esomrazole Magnesium Trihydrate Imp. D : 5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphonyl]-1H-benzimidazole (Omrazole Sulphone); Omrazole impurity D CRS; 5-Methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfonyl}-1H-benzimidazole; 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfonyl]benzimidazole; 6-Methoxy-2-((4-Methoxy-3,5-diMethylpyridin-2-yl)Methylsulfonyl)-1H-benzo[d]iMidazole; Esomeprazole Impurity 4; 1H-BenziMidazole, 6-Methoxy -2-[[(4-Methoxy-3,5-diMethyl-2-pyridinyl)Methyl]sulfonyl]; Omrazole Impurity D (Omrazole Sulfone); Methoxy-2-[[(4-Methxoy-3,5-diMethylpyridin-2-yl)Methyl]sulfonyl]-1H-benziMidazole(oMrazole-sulfone); Esomrazole Magnesium Trihydrate D; 5-Methoxy-2-[[(4-Methxoy-3,5-diMethylpyridin-2-yl)Methyl]sulfonyl]-1H-benziMidazole(oMrazole-sulfone); Esomrazole Impurity D H168/66; Omrazole Impurity D (Esomrazole Impurity D); OMrazole IMpurity-D R C A); Esomrazole Impurity D; BEN501; 6-Methoxy-2-{[(4-Methoxy-3,5-diMethylpyridin-2-yl)Methyl]sulfonyl}-1H-benziMidazole; Omrazole Related Compound A (15 mg); 5-Methoxy-2-(((4-Methoxy-3,5-diMethylpyridin-2-yl)Methyl)sulfonyl)-1H-benzo[d]iMidazole; Esomrazole Impurity D/Esomrazole RC A/Omrazole Impurity D /Omrazole Sulfone; 6-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole; OMRAZOLE RELATED COMPOUND A (15 MG) (OMRAZOLE SULFONE) (AS); Esomrazole SodiumImpurity Ⅰ; Esomrazole sodium D(H168/66); Esomrazole Impurity D/ Esomrazole Related Compound A (Omrazole Impurity D/ Omrazole Sulfone); 6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sul; Omrazole Sulfone Omrazole Related Compound A; (OMRAZOLE SULFONE) (AS); EsoMrazol iMpurity D; Omrazole metabolite Omrazole sulfone; OMRAZOLE SULPHONE; Omrazole impurity 4/Omrazole Impurity D/Omrazole Sulfone/5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphonyl]-1H-benzimidazole; OMrazole Related CoMpound A (AS); 5-Methoxy-2-{[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfonyl}-1H-benzimidazole; IMp. D : 5-Methoxy-2-[[(4-Methoxy-3,5-diMethylpyridin-2-yl)Methyl]sulphonyl]-1H- benziMidazole (OMrazole Sulphone); Esomrazole impurity 1/Esomrazole Impurity D/Omrazole Impurity D/Omrazole Sulfone/5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphonyl]-1H-benzimidazole; Omeprazole metabolite Omeprazole sulfone; Omrazole Impurity D(Sulfoxide); Omrazole Related Compound A (15 mg) (5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfonyl]-1H-benzimidazole); Omrazole impurity DQ: What is Omrazole impurity D Q: What is the CAS Number of Omrazole impurity D Q: What is the storage condition of Omrazole impurity D Q: What e the applications of Omrazole impurity D; 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfonyl]- 1H-benzimidazol; 5-Methoxy-2-[[(4-Methxoy-3,5-diMethylpyridin-2-yl)Methyl]sulfonyl]-1H-benziMidazole; 5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfonyl)-1H-benzo[d]imidazole; Omrazole Impurity D（; Omrazole Impurity D (Omrazole Sulfone/ Esomrazole Impurity D/ Esomrazole Related Compound A); 5-Methoxy-2-((4-Methoxy-3,5-diMethylpyridin-2-yl)Methylsulfonyl)-1H-benzo[d]iMidazole (Reld D); Omrazole Related Compound A (5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfonyl]-1; Esomrazole Impurities544; 1H-Benzimidazole,6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfonyl]; Omeprazole sulphone; Omrazole Related Compound A (15 mg) (Omrazole Sulfone or 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphonyl]-1H-benzimidazole); Esomrazole Impurity D(Omrazole Impurity D); Esomrazole Sodium Impurity D

物化性质

• 密度: 1.3±0.1 g/cm3
• 沸点: 599.3±60.0 °C at 760 mmHg
• 熔点: 80-82ºC
• 分子式: C₁₇H₁₉N₃O₄S
• 分子量: 361.415
• 闪点: 316.2±32.9 °C
• 精确质量: 361.109619
• PSA: 102.55000
• LogP: 3.87
• 蒸汽压: 0.0±1.7 mmHg at 25°C
• 折射率: 1.609
• 储存条件: -20°C Freezer

生物活性

• 描述: Omeprazole sulfone是Omeprazole的代谢物。
• 相关类别:
  信号通路 >> 其他 >> 其他
  研究领域 >> 其他

安全

• 符号: GHS07
• 信号词: Warning
• 危害声明: H315-H319-H335
• 警示性声明: P261-P305 + P351 + P338
• 危害码 (欧洲): Xi
• 风险声明 (欧洲): 36/37/38
• 安全声明 (欧洲): 26-36
• 危险品运输编码: NONH for all modes of transport
• 海关编码: 2933990090

海关

海关编码	2933990090
中文概述	2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素	品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期
Summary	2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%